Google has introduced AlphaGenome, an advanced artificial intelligence system aimed at decoding the human genome and revealing how genetic variations contribute to disease. The tool was presented in Paris, where researchers described it as a significant breakthrough in genomic research.
Unlike traditional models that focus on protein-coding genes, AlphaGenome concentrates on non-coding DNA. This portion of the genome, while often overlooked, plays a crucial role in controlling when and how genes are activated. According to Google scientists in Paris, the system can examine exceptionally long DNA sequences while maintaining high analytical precision.
Developed by Google DeepMind, AlphaGenome was trained using publicly available genomic data from both humans and mice. The model is designed to predict how genetic alterations affect cellular behavior and internal biological mechanisms.
While the launch has been welcomed by independent researchers in the UK, experts have emphasized the need for restraint. Scientists from the University of Cambridge and the Francis Crick Institute pointed out that environmental influences remain a major factor in disease development, limiting how much AI alone can explain genetic outcomes.
